Latest DNLI reports update at 2024-05-07: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Denali Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Denali Therapeutics logo
Denali Therapeutics DNLI
$ 18.67 -1.22%
mail-toReport an Error

Denali Therapeutics EV/EBITDA Ratio 2011-2024 | DNLI

Annual EV/EBITDA Ratio Denali Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-14.1 84.8 -10.5 -43 -1.56 - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
84.8 -43 3.15